je.st
news
Tag: presentation
New KEYTRUDA (pembrolizumab) Data Accepted for Presentation at SITC 2016 Annual Meeting
2016-11-07 13:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. First Presentation of Overall Survival Data in Patients with Advanced Bladder (Urothelial) Cancer from KEYNOTE-045 Study KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that new data investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in patients with previously treated advanced urothelial cancer will be presented at the Society for Immunotherapy of Cancers (SITC) 31st Annual Meeting, Nov. 9-13. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orKim Hamilton, 908-740-1863orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: data
meeting
accepted
annual
Benefit cost analysis overview presentation slides
2016-11-05 05:30:34| PortlandOnline
PDF Document, 798kbCategory: Unreinforced Masonry (URM) Seismic Retrofit Project
Tags: cost
analysis
overview
benefit
Pollution Prevention Services Presentation
2016-11-04 01:07:05| PortlandOnline
PDF Document, 688kbCategory: November 1, 2016 Materials
Tags: services
presentation
prevention
pollution
BES and Water Budget Presentation
2016-11-04 00:38:34| PortlandOnline
PDF Document, 1,170kbCategory: October 25 Budget Subcommittee
Tags: water
presentation
budget
bes
September 20, 2016 Briefing: Transportation System Plan Presentation
2016-11-03 22:30:01| PortlandOnline
PDF Document, 3,956kbCategory: City Council Briefings and Work Sessions
Tags: system
september
plan
presentation
Sites : [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] next »